79250207 - VETTER-JECT

Information

• Trademark
• 79250207

• Source

• Serial Number

  79250207

• Registration Number

  6791709

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 39 - Transport
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 24, 2018
  6 years ago

• Registration Date

  July 19, 2022
  2 years ago

• Transaction Date

  November 14, 2022
  2 years ago

• Status Date

  July 19, 2022
  2 years ago

• Published for Opposition Date

  May 03, 2022
  3 years ago

• Location Date

  July 19, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  AGREDA, SAMANTHA LEIGH

• Attorney Docket Number

  0013048

  Attorney Name

  M. Scott Alprin

  Law Office Assigned Location Code

  N50

• Owners

  • VETTER PHARMA-FERTIGUNG GMBH & CO. KG

Case File Statements

• GS0391: Bottling services, namely, bottling of liquid and solid substances, in particular of pharmaceuticals, medicines and solutions
• GS0051: Pharmaceutical preparations and medicines for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; pharmaceutical solutions for oral administration in the nature of sterile aseptic solutions, namely in the form of tablets, pills, capsules, drops, medical juice and medical syrup, all for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; injectable pharmaceuticals in the nature of antibody solutions, biologicals, peptides, polypeptides, proteins, enzymes, nucleic acids, coagulation factors, interferons, phosphonates and bisphosphonates, growth factors, hormones, hormoneantagonists, insulin, heparins, low molecular heparins and sulfur hexafluoride, all for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; eyedrops, contact lens solutions; medicated compresses; medical plasters, materials for dressings in the nature of bandages, wadding and gauze; filled medical injection devices, in particular syringes and instruments for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes, all sold filled with pharmaceutical preparations for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia
• PM0001: VETTER-INJECT
• GS0101: Empty medical injection devices, in particular syringes and instruments for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes, all sold empty; medicine containers for administering medicines, of glass and/or plastic in the nature of medical syringes, injectors, auto-injectors, disposable syringes and disposable cannulae; syringe holders being containers specially adapted for holding medical syringes; medical syringes, disposable syringes, and disposable cannulae sold either individually or in combination, all for medical purposes
• GS0421: Development of syringes and instruments for injections, injectors and packaging for the aforesaid goods; laboratory tests in the nature of scientific testing in the fields of chemical, physics and process engineering; product development and conducting of scientific tests in the fields of pharmacological and microbiological processes

Case File Event Statements

• 11/14/2022 - 2 years ago

  51 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 10/22/2022 - 2 years ago

  50 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 10/22/2022 - 2 years ago

  49 - FINAL DISPOSITION PROCESSED Type: FIMP

• 10/19/2022 - 2 years ago

  48 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 7/19/2022 - 2 years ago

  47 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 7/19/2022 - 2 years ago

  46 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/9/2022 - 2 years ago

  45 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/3/2022 - 3 years ago

  44 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/3/2022 - 3 years ago

  43 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/13/2022 - 3 years ago

  42 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 4/13/2022 - 3 years ago

  41 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 4/13/2022 - 3 years ago

  40 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/27/2022 - 3 years ago

  39 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/26/2022 - 3 years ago

  38 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/25/2022 - 3 years ago

  37 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/25/2022 - 3 years ago

  36 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 9/27/2021 - 3 years ago

  35 - NOTIFICATION OF SUBSEQUENT FINAL EMAILED Type: GNS1

• 9/27/2021 - 3 years ago

  34 - CONTINUATION OF FINAL REFUSAL E-MAILED Type: GNCF

• 9/27/2021 - 3 years ago

  33 - ACTION CONTINUING A FINAL - COMPLETED Type: CNCF

• 7/28/2021 - 3 years ago

  32 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK

• 5/16/2021 - 3 years ago

  31 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 4/28/2021 - 4 years ago

  30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 4/28/2021 - 4 years ago

  29 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 10/2/2020 - 4 years ago

  28 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 3/12/2020 - 5 years ago

  27 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 3/12/2020 - 5 years ago

  26 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 3/12/2020 - 5 years ago

  25 - SUSPENSION LETTER WRITTEN Type: CNSL

• 3/10/2020 - 5 years ago

  24 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/10/2020 - 5 years ago

  23 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/10/2020 - 5 years ago

  22 - ASSIGNED TO LIE Type: ALIE

• 3/4/2020 - 5 years ago

  21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 3/5/2020 - 5 years ago

  20 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 3/5/2020 - 5 years ago

  19 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 3/5/2020 - 5 years ago

  18 - SUSPENSION LETTER WRITTEN Type: CNSL

• 12/6/2019 - 5 years ago

  17 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN

• 11/29/2019 - 5 years ago

  16 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV

• 9/5/2019 - 5 years ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 9/5/2019 - 5 years ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 9/5/2019 - 5 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 8/13/2019 - 5 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/13/2019 - 5 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/13/2019 - 5 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/2/2019 - 6 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 2/13/2019 - 6 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 2/12/2019 - 6 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 2/5/2019 - 6 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/4/2019 - 6 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/1/2019 - 6 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 1/28/2019 - 6 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/28/2019 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 1/24/2019 - 6 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR